RU2017131253A - Способы получения фторкетолидов - Google Patents
Способы получения фторкетолидов Download PDFInfo
- Publication number
- RU2017131253A RU2017131253A RU2017131253A RU2017131253A RU2017131253A RU 2017131253 A RU2017131253 A RU 2017131253A RU 2017131253 A RU2017131253 A RU 2017131253A RU 2017131253 A RU2017131253 A RU 2017131253A RU 2017131253 A RU2017131253 A RU 2017131253A
- Authority
- RU
- Russia
- Prior art keywords
- compound
- formula
- derivative
- base
- hydroxy
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 claims 11
- 239000002585 base Substances 0.000 claims 10
- 150000003839 salts Chemical class 0.000 claims 8
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 6
- IXXFZUPTQVDPPK-ZAWHAJPISA-N (1r,2r,4r,6r,7r,8r,10s,13r,14s)-17-[4-[4-(3-aminophenyl)triazol-1-yl]butyl]-7-[(2s,3r,4s,6r)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-13-ethyl-10-fluoro-6-methoxy-2,4,6,8,10,14-hexamethyl-12,15-dioxa-17-azabicyclo[12.3.0]heptadecane-3,9,11,16-tet Chemical compound O([C@@H]1[C@@H](C)C(=O)[C@](C)(F)C(=O)O[C@@H]([C@]2(OC(=O)N(CCCCN3N=NC(=C3)C=3C=C(N)C=CC=3)[C@@H]2[C@@H](C)C(=O)[C@H](C)C[C@@]1(C)OC)C)CC)[C@@H]1O[C@H](C)C[C@H](N(C)C)[C@H]1O IXXFZUPTQVDPPK-ZAWHAJPISA-N 0.000 claims 3
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims 3
- 229950008588 solithromycin Drugs 0.000 claims 3
- 125000002252 acyl group Chemical group 0.000 claims 2
- 150000001412 amines Chemical class 0.000 claims 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims 2
- 125000004432 carbon atom Chemical group C* 0.000 claims 2
- 239000012025 fluorinating agent Substances 0.000 claims 2
- 239000001257 hydrogen Substances 0.000 claims 2
- 229910052739 hydrogen Inorganic materials 0.000 claims 2
- 150000002772 monosaccharides Chemical class 0.000 claims 2
- 239000001301 oxygen Substances 0.000 claims 2
- 229910052760 oxygen Inorganic materials 0.000 claims 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 2
- 239000007858 starting material Substances 0.000 claims 2
- 125000000547 substituted alkyl group Chemical group 0.000 claims 2
- 239000002253 acid Substances 0.000 claims 1
- 150000004982 aromatic amines Chemical class 0.000 claims 1
- 125000004122 cyclic group Chemical group 0.000 claims 1
- 150000004985 diamines Chemical class 0.000 claims 1
- 125000002147 dimethylamino group Chemical group [H]C([H])([H])N(*)C([H])([H])[H] 0.000 claims 1
- 125000000250 methylamino group Chemical group [H]N(*)C([H])([H])[H] 0.000 claims 1
- 239000012022 methylating agents Substances 0.000 claims 1
- 229910052757 nitrogen Inorganic materials 0.000 claims 1
- 125000004433 nitrogen atom Chemical group N* 0.000 claims 1
- 239000012363 selectfluor Substances 0.000 claims 1
- IMNIMPAHZVJRPE-UHFFFAOYSA-N triethylene diamine Substances C1CN2CCN1CC2 IMNIMPAHZVJRPE-UHFFFAOYSA-N 0.000 claims 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
- C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H1/00—Processes for the preparation of sugar derivatives
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Saccharide Compounds (AREA)
- Pyrane Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562129305P | 2015-03-06 | 2015-03-06 | |
| US62/129,305 | 2015-03-06 | ||
| PCT/US2016/021085 WO2016144833A1 (en) | 2015-03-06 | 2016-03-05 | Processes for preparing fluoroketolides |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| RU2017131253A true RU2017131253A (ru) | 2019-04-08 |
Family
ID=56880477
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2017131253A RU2017131253A (ru) | 2015-03-06 | 2016-03-05 | Способы получения фторкетолидов |
Country Status (19)
| Country | Link |
|---|---|
| US (2) | US20180044365A1 (enExample) |
| EP (1) | EP3265100A4 (enExample) |
| JP (1) | JP6773672B2 (enExample) |
| KR (1) | KR20170133377A (enExample) |
| CN (1) | CN107405355A (enExample) |
| AU (1) | AU2016230027A1 (enExample) |
| BR (1) | BR112017019176A2 (enExample) |
| CA (1) | CA2978731A1 (enExample) |
| CL (1) | CL2017002255A1 (enExample) |
| CO (1) | CO2017010143A2 (enExample) |
| HK (1) | HK1247097A1 (enExample) |
| IL (1) | IL254306A0 (enExample) |
| MX (2) | MX2017011454A (enExample) |
| PE (1) | PE20180219A1 (enExample) |
| RU (1) | RU2017131253A (enExample) |
| SG (2) | SG11201707215XA (enExample) |
| TW (1) | TW201638102A (enExample) |
| WO (1) | WO2016144833A1 (enExample) |
| ZA (1) | ZA201706505B (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101917850B (zh) | 2007-10-25 | 2016-01-13 | 森普拉制药公司 | 大环内酯类抗菌剂的制备方法 |
| DK2358379T3 (en) | 2008-10-24 | 2016-03-07 | Cempra Pharmaceuticals Inc | BIOFORSVAR USING TRIAZOLHOLDIGE macrolides |
| US9937194B1 (en) | 2009-06-12 | 2018-04-10 | Cempra Pharmaceuticals, Inc. | Compounds and methods for treating inflammatory diseases |
| MX2014011537A (es) | 2012-03-27 | 2015-02-10 | Cempra Pharmaceuticals Inc | Formulaciones parenterales para la administracion de antibioticos macrolidos. |
| WO2014152326A1 (en) | 2013-03-14 | 2014-09-25 | Cempra Pharmaceuticals, Inc. | Methods for treating respiratory diseases and formulations therefor |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3668282A (en) * | 1970-05-08 | 1972-06-06 | Stauffer Chemical Co | Stabilized mixture employing n-(beta-0,0-dialkyldithiophosphoryl) aryl sulfonamides |
| EP3738591A3 (en) * | 2003-03-10 | 2021-03-24 | Merck Sharp & Dohme Corp. | Novel antibacterial agents |
| US7595300B2 (en) * | 2005-12-13 | 2009-09-29 | Kosan Biosciences Incorporated | 7-quinolyl ketolide antibacterial agents |
| CN101917850B (zh) * | 2007-10-25 | 2016-01-13 | 森普拉制药公司 | 大环内酯类抗菌剂的制备方法 |
| US8376805B2 (en) * | 2008-07-24 | 2013-02-19 | Ideo Llc | Printable pre-sewn stuffed toy composite sheets |
| KR101567658B1 (ko) * | 2011-03-01 | 2015-11-09 | 욱크하르트 리미티드 | 케톨리드 중간체의 제조 방법 |
| WO2014152326A1 (en) * | 2013-03-14 | 2014-09-25 | Cempra Pharmaceuticals, Inc. | Methods for treating respiratory diseases and formulations therefor |
| BR112015023670A2 (pt) * | 2013-03-15 | 2017-07-18 | Cempra Pharmaceuticals Inc | processo para preparar um composto |
| BR112015025159A2 (pt) * | 2013-04-04 | 2017-07-18 | Harvard College | macrolídeos e métodos de sua preparação e uso |
-
2016
- 2016-03-05 US US15/555,701 patent/US20180044365A1/en not_active Abandoned
- 2016-03-05 BR BR112017019176A patent/BR112017019176A2/pt not_active Application Discontinuation
- 2016-03-05 JP JP2017546856A patent/JP6773672B2/ja active Active
- 2016-03-05 EP EP16762268.7A patent/EP3265100A4/en not_active Withdrawn
- 2016-03-05 WO PCT/US2016/021085 patent/WO2016144833A1/en not_active Ceased
- 2016-03-05 PE PE2017001500A patent/PE20180219A1/es not_active Application Discontinuation
- 2016-03-05 SG SG11201707215XA patent/SG11201707215XA/en unknown
- 2016-03-05 KR KR1020177028547A patent/KR20170133377A/ko not_active Withdrawn
- 2016-03-05 MX MX2017011454A patent/MX2017011454A/es unknown
- 2016-03-05 CA CA2978731A patent/CA2978731A1/en not_active Abandoned
- 2016-03-05 RU RU2017131253A patent/RU2017131253A/ru unknown
- 2016-03-05 AU AU2016230027A patent/AU2016230027A1/en not_active Abandoned
- 2016-03-05 SG SG10201908248P patent/SG10201908248PA/en unknown
- 2016-03-05 CN CN201680021207.4A patent/CN107405355A/zh active Pending
- 2016-03-05 HK HK18106628.7A patent/HK1247097A1/zh unknown
- 2016-03-07 TW TW105106986A patent/TW201638102A/zh unknown
-
2017
- 2017-09-04 IL IL254306A patent/IL254306A0/en unknown
- 2017-09-06 MX MX2020007742A patent/MX2020007742A/es unknown
- 2017-09-06 CL CL2017002255A patent/CL2017002255A1/es unknown
- 2017-09-27 ZA ZA2017/06505A patent/ZA201706505B/en unknown
- 2017-10-05 CO CONC2017/0010143A patent/CO2017010143A2/es unknown
-
2020
- 2020-04-23 US US16/856,754 patent/US20210070797A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| ZA201706505B (en) | 2021-04-28 |
| KR20170133377A (ko) | 2017-12-05 |
| JP6773672B2 (ja) | 2020-10-21 |
| PE20180219A1 (es) | 2018-01-31 |
| MX2017011454A (es) | 2018-01-23 |
| IL254306A0 (en) | 2017-11-30 |
| EP3265100A1 (en) | 2018-01-10 |
| CL2017002255A1 (es) | 2018-05-11 |
| HK1247097A1 (zh) | 2018-09-21 |
| CA2978731A1 (en) | 2016-09-15 |
| US20180044365A1 (en) | 2018-02-15 |
| JP2018508537A (ja) | 2018-03-29 |
| CN107405355A (zh) | 2017-11-28 |
| SG10201908248PA (en) | 2019-10-30 |
| MX2020007742A (es) | 2020-09-25 |
| CO2017010143A2 (es) | 2018-02-28 |
| BR112017019176A2 (pt) | 2018-04-24 |
| US20210070797A1 (en) | 2021-03-11 |
| AU2016230027A1 (en) | 2017-09-28 |
| TW201638102A (zh) | 2016-11-01 |
| SG11201707215XA (en) | 2017-10-30 |
| EP3265100A4 (en) | 2019-01-09 |
| WO2016144833A1 (en) | 2016-09-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2017131253A (ru) | Способы получения фторкетолидов | |
| RU2015102723A (ru) | Получение 2-(5-бром-4-(4-циклопропилнафталин-1-ил)-4h-1,2,4-триазол-3-илтио)уксусной кислоты | |
| IL292754B1 (en) | Synthesis of n,n-dimethyltryptamine-type compounds | |
| MY150289A (en) | Derivatives of indole-2-carboxamides and of azaindole-2-carboxamides substituted with a silanyl group, preparation thereof and therapeutic use thereof | |
| AR079752A1 (es) | Prodrogas de sales de amonio cuaternario | |
| AR070950A1 (es) | Compuestos derivados de amina, composiciones farmaceuticas de ellos, compuestos inhibidores de produccion de 11-cis-retinol y metodos para tratar enfermedades y trastornos oftalmicos | |
| AR088296A1 (es) | Citramida de rasagilina, proceso de preparación y composicion farmaceutica | |
| RU2018111201A (ru) | Фунгицидная композиция для применения в сельском хозяйстве и садоводстве | |
| AR083069A1 (es) | Analogos de nucleotidos sustituidos | |
| MX2014015501A (es) | Carboxamidas heterociclicas fungicidas. | |
| AR044874A1 (es) | Derivados de 4- cianopirazol-3 - carboxamida, su preparacion y su aplicacion en terapeutica | |
| JP2015532645A5 (enExample) | ||
| EA201990455A1 (ru) | КОНДЕНСИРОВАННОЕ ТРИЦИКЛИЧЕСКОЕ ПРОИЗВОДНОЕ γ-АМИНОКИСЛОТЫ, СПОСОБ ЕГО ПОЛУЧЕНИЯ И ЕГО МЕДИЦИНСКОЕ ПРИМЕНЕНИЕ | |
| JP2018508537A5 (enExample) | ||
| JP2019535723A5 (enExample) | ||
| RU2016123144A (ru) | Сложноэфирное хиральное соединение (n-замещенный имидазол)-карбоновой кислоты, содержащее простую эфирную боковую цепь, его получение и применение | |
| RU2018132264A (ru) | Промежуточные продукты в синтезе эрибулина и соответствующие способы синтеза | |
| RU2013136895A (ru) | Новое бициклическое соединение или его соль | |
| RU2017123537A (ru) | Средство для деформирующей обработки волос | |
| JP2013537240A5 (enExample) | ||
| BR112017018580A2 (pt) | p-toluenossulfonato para inibidor de mek quinase, e forma cristalina do mesmo e método de preparação para tal | |
| RU2016106125A (ru) | Соли дасатиниба в кристаллической форме | |
| RU2014124531A (ru) | (1r,4r) 7-оксо-2-азабицикло[2.2.2]окт-5-ен и его производные | |
| RU2019127038A (ru) | N1-(4-(5-(циклопропилметил)-1-метил-1h-пиразол-4-ил)пиридин-2-ил)циклогексан-1,4-диаминовые производные и родственные соединения в качестве ингибиторов сk1 и/или irak1 для лечения рака | |
| RU2016116036A (ru) | Производное циклического амина и его фармацевтическое применение |